In a new clinical trial, DermaPep™ A530 has been proved to be very powerful
anti-irritation, anti-redness and anti-inflammatory agent.
In a clinical study conducted on 32 healthy Asian female volunteers, aged 29 to 60,
a local inflammation was created on the inner arm by the application of patch containing
sodium lauryl sulfate (SLS) with or without a cream containing 2% DermaPep™ A530.
A study has confirmed the significant reduction of the global inflammation score
(combining erythema, oedema and scaling). In addition, DermaPep™ A530 greatly lowered
skin redness and TEWL (trans epidermal water loss) values.
In in-vitro study, DermaPep™ A530 significantly reduced the expression as well as
production of pro-inflammatory cytokines, IL-1a, IL-8 and TNF-a, three most important
cytokines that have been known to cause skin irritation and sensitization.
For further information, please check it in product section.
▶DermaPep™ A530
